SB 265

  • Texas Senate Bill
  • 88th Legislature (2023)
  • Introduced in Senate Apr 28, 2023
  • Passed Senate Apr 20, 2023
  • House
  • Governor

Relating to required reports of certain vaccine-related or drug-related adverse events.

Votes


No votes to display

Actions


Apr 28, 2023

House

Referred to Public Health

  • Referral-Committee
Public Health

House

Read first time

Apr 20, 2023

Senate

Laid before the Senate

House

Received from the Senate

Senate

Reported engrossed

Senate

Record vote

Senate

Read 2nd time & passed to engrossment

Senate

Read 3rd time

Senate

Record vote

Senate

Three day rule suspended

Senate

Vote recorded in Journal

Senate

Passed

Senate

Placed on local & uncontested calendar

Apr 17, 2023

Senate

Committee report printed and distributed

Senate

Reported favorably as substituted

Senate

Recommended for local & uncontested calendar

Apr 12, 2023

Senate

Vote taken in committee

Senate

Considered in public hearing

Mar 22, 2023

Senate

Scheduled for public hearing on . . .

Senate

Left pending in committee

Senate

Testimony taken in committee

Senate

Considered in public hearing

Feb 15, 2023

Senate

Read first time

Senate

Referred to Health & Human Services

  • Referral-Committee
Health & Human Services

Feb 08, 2023

Senate

Co-author authorized

Dec 06, 2022

Senate

Filed

Senate

Received by the Secretary of the Senate

Bill Text

Bill Text Versions Format
Introduced PDF HTML
Senate Committee Report PDF HTML
Engrossed PDF HTML

Related Documents

Document Format
Witness List (Senate Committee Report) HTML
Fiscal Note (Senate Committee Report) HTML
Fiscal Note (Introduced) HTML
Analysis (Senate Committee Report) HTML
Analysis (Introduced) HTML

Sources

Data on Open States is updated periodically throughout the day from the official website of the Texas Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.